Subtype
Malignant Large Intestinal Neoplasm
CI-CAN-00003173Explore in graph →
1,622 active trials21 approved drugs383 evidence items
- NCIt
- C215202
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003173Explore in graph →
Clinical trials
7,502 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (742)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05427214 | Imaging Study on Halcyon 4.0 System for Patients Receiving Radiation Therapy(Dragon) | completed | N/A | 52 | Washington University School of MedicineOTHER | 1 | Oct 21, 2024 | clinicaltrials |
| NCT05959564 | A Chatbot Intervention for Reducing HPV Vaccine Hesitancy | completed | N/A | 456 | University of Maryland, College ParkOTHER | 1 | Oct 21, 2024 | clinicaltrials |
| NCT04679597 | Total Neoadjuvant Therapy Versus Standard Therapy of Locally Advanced Rectal Cancer With High Risk Factors for Failure | completed | — | 161 | Institute of Oncology LjubljanaOTHER | 0 | Oct 17, 2024 | clinicaltrials |
| NCT03100461 | Adaptive Intervention to Maximize Colorectal Screening in Safety Net Populations(AIMSS) | completed | N/A | 500 | University of Kansas Medical CenterOTHER | 1 | Oct 15, 2024 | clinicaltrials |
| NCT03435107 | Durvalumab for MSI-H or POLE Mutated Metastatic Colorectal Cancer | completed | Phase 2 | 33 | Asan Medical CenterOTHER | 1 | Oct 15, 2024 | clinicaltrials |
| NCT05022719 | Technical Feasibility Evaluation of Mucosal Staining During Colon Capsule Endoscopy (CCE) Procedure in Colorectal Cancer (CRC) High Risk Population, When Using MB-MMX | completed | N/A | 8 | Medtronic - MITGINDUSTRY | 1 | Oct 15, 2024 | clinicaltrials |
| NCT05985239 | Virtual Ileostomy Versus Diverting Ileostomy | completed | — | 612 | fan liOTHER | 1 | Oct 15, 2024 | clinicaltrials |
| NCT06638957 | Impact of the COVID-19 Pandemic on Oncologic Outcomes in Colorectal Cancer | completed | — | 14,951 | In Ja ParkOTHER | 1 | Oct 15, 2024 | clinicaltrials |
| NCT03087591 | APN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid Tumors That Cannot Be Removed by Surgery | completed | Phase 1 | 11 | Wake Forest University Health SciencesOTHER | 1 | Oct 10, 2024 | clinicaltrials |
| NCT06313268 | Safety of Effivia®, a Bevacizumab Biosimilar | completed | — | 83 | Laboratorios LiomontINDUSTRY | 1 | Oct 10, 2024 | clinicaltrials |
| NCT02754856 | Tremelimumab and Durvalumab in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery | completed | Phase 1 | 24 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 9, 2024 | clinicaltrials |
| NCT02175095 | [18F]FLT-PET as a Predictive Imaging Biomaker of Treatment Responses to Regorafenib | completed | N/A | 68 | Asan Medical CenterOTHER | 1 | Oct 4, 2024 | clinicaltrials |
| NCT02563002 | Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177) | completed | Phase 3 | 307 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Oct 3, 2024 | clinicaltrials |
| NCT06625008 | Preoperative 3D Models and Shared Decision-making | completed | N/A | 51 | Vanderbilt University Medical CenterOTHER | 1 | Oct 3, 2024 | clinicaltrials |
| NCT04739722 | Colorectal Cancer and Pre-Cancerous Adenoma Non-Invasive Detection Test Study(CRC-PREVENT) | completed | N/A | 14,263 | Geneoscopy, Inc.INDUSTRY | 1 | Oct 1, 2024 | clinicaltrials |
| NCT06621225 | Artificial Intelligence in Colonoscopy(AIColonoscopy) | completed | N/A | 264 | Pankaj PatelOTHER | 1 | Oct 1, 2024 | clinicaltrials |
| NCT02323464 | Prevalence of Sleep Apnea in Patients Undergoing Surgery for Colorectal Cancer | completed | — | 212 | Karl A FranklinOTHER | 1 | Sep 27, 2024 | clinicaltrials |
| NCT03251378 | A Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors and Colorectal, and Breast Cancers | completed | Phase 1 | 129 | Hutchison Medipharma LimitedINDUSTRY | 1 | Sep 25, 2024 | clinicaltrials |
| NCT05646030 | Feasibility, Reliability, and Satisfaction of CEA Using Home Based (Automated) Capillary Blood Sampling(CASA-I) | completed | N/A | 102 | Erasmus Medical CenterOTHER | 1 | Sep 25, 2024 | clinicaltrials |
| NCT03476707 | Association of Anemia With Hospital Costs in Elective Colorectal Surgery | completed | — | 851 | Ottawa Hospital Research InstituteOTHER | 0 | Sep 24, 2024 | clinicaltrials |
| NCT04713891 | A Study of KF-0210 in Advanced Solid Tumors Patients | completed | Phase 1 | 14 | Keythera Pharmaceuticals (Australia) Pty LtdINDUSTRY | 1 | Sep 24, 2024 | clinicaltrials |
| NCT04737187 | Phase III Study of Trifluridine/Tipiracil With and Without Bevacizumab in Refractory Metastatic Colorectal Cancer Patients(SUNLIGHT) | completed | Phase 3 | 492 | Taiho Oncology, Inc.INDUSTRY | 14 | Sep 24, 2024 | clinicaltrials |
| NCT01210313 | Physical Activity for Reduction of Recurrence Rate After Adjuvant Chemotherapy for Localised Colorectal Carcinoma | completed | — | 30 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Sep 19, 2024 | clinicaltrials |
| NCT01607957 | Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies(RECOURSE) | completed | Phase 3 | 800 | Taiho Oncology, Inc.INDUSTRY | 13 | Sep 19, 2024 | clinicaltrials |
| NCT03475004 | Study of Pembrolizumab, Binimetinib, and Bevacizumab in Patients With Refractory Colorectal Cancer | completed | Phase 2 | 53 | University of Colorado, DenverOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT03853473 | Prehabilitation of Frail Surgical Cancer Patients Using Remote Ischemic Preconditioning(Prehab) | completed | N/A | 17 | Medical College of WisconsinOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT04474470 | A Study to Evaluate NT219 Alone and in Combination with ERBITUX® (Cetuximab) in Adults with Advanced Solid Tumors and Head and Neck Cancer | completed | Phase 1 / Phase 2 | 52 | TyrNovo Ltd.INDUSTRY | 2 | Sep 19, 2024 | clinicaltrials |
| NCT05153746 | Adenoma Detection Rate of 3D Colonoscopy | completed | N/A | 318 | National Taiwan University HospitalOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT05344950 | Connecting Audio and Radio Sensing Systems to Improve Care at Home(AURA) | completed | — | 13 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT05611151 | Real-time Computer-Aided Detection of Colonic Adenomas With NEC WISE VISION® Endoscopy(COLOWISE) | completed | N/A | 830 | NEC CorporationINDUSTRY | 4 | Sep 19, 2024 | clinicaltrials |
| NCT06586307 | Estimating Lymphocyte Counts from DNA Methylation | completed | — | 49 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06597903 | A Monocentric Study to Investigate a New Low Dose Oral Gut Cleansing Solution | completed | Phase 2 | 36 | NorgineINDUSTRY | 1 | Sep 19, 2024 | clinicaltrials |
| NCT03800602 | Nivolumab and Metformin in Patients With Treatment Refractory MSS Colorectal Cancer | completed | Phase 2 | 29 | Emory UniversityOTHER | 1 | Sep 5, 2024 | clinicaltrials |
| NCT02466009 | Regorafenib in Metastatic Colorectal Cancer | completed | Phase 2 | 27 | University of RochesterOTHER | 1 | Sep 4, 2024 | clinicaltrials |
| NCT02767986 | Where Culture Meets Genetics: Exploring Latinas Causal Attributions of Breast and Colon Cancer and Models of Disease Inheritance | completed | — | 22 | National Human Genome Research Institute (NHGRI)NIH | 1 | Sep 3, 2024 | clinicaltrials |
| NCT02860546 | A Study Evaluating TAS-102 Plus Nivolumab in Patients With MSS CRC | completed | Phase 2 | 18 | Taiho Oncology, Inc.INDUSTRY | 1 | Sep 3, 2024 | clinicaltrials |
| NCT03263429 | Novel PET/CT Imaging Biomarkers of CB-839 in Combination With Panitumumab and Irinotecan in Patients With Metastatic and Refractory RAS Wildtype Colorectal Cancer | completed | Phase 1 / Phase 2 | 29 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Aug 30, 2024 | clinicaltrials |
| NCT02705300 | Side Effects to FOLFOXIRI + Tocotrienol/Placebo as First Line Treatment of Metastatic Colorectal Cancer | completed | Phase 2 | 70 | Vejle HospitalOTHER | 1 | Aug 29, 2024 | clinicaltrials |
| NCT02431676 | Survivorship Promotion In Reducing IGF-1 Trial(SPIRIT) | completed | Phase 2 | 121 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 28, 2024 | clinicaltrials |
| NCT04192071 | Virtual Human Delivered Nutrition Module for Colorectal Cancer Prevention | completed | N/A | 139 | University of FloridaOTHER | 1 | Aug 28, 2024 | clinicaltrials |
| NCT05875584 | Exploratory Study of a Novel Based rbcDNA Liquid Biopsy Technique for Colorectal Cancer Early Detection | completed | — | 598 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Aug 27, 2024 | clinicaltrials |
| NCT02873195 | Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer | completed | Phase 2 | 133 | Academic and Community Cancer Research UnitedOTHER | 1 | Aug 23, 2024 | clinicaltrials |
| NCT03265483 | Magnesium Treatment on Vitamin D Metabolism in Participants Completed Personalized Prevention of Colorectal Cancer Trial | completed | N/A | 180 | Vanderbilt University Medical CenterOTHER | 1 | Aug 23, 2024 | clinicaltrials |
| NCT03267316 | A First-in-Human Study of CAN04 in Patients With Solid Malignant Tumors(CANFOUR) | completed | Phase 1 / Phase 2 | 167 | Cantargia ABINDUSTRY | 11 | Aug 22, 2024 | clinicaltrials |
| NCT03981614 | Binimetinib and Palbociclib or TAS-102 in Treating Patients With KRAS and NRAS Mutant Metastatic or Unresectable Colorectal Cancer | completed | Phase 2 | 102 | Academic and Community Cancer Research UnitedOTHER | 1 | Aug 22, 2024 | clinicaltrials |
| NCT05086627 | Short-course Radiotherapy Followed by Tislelizumab + CapeOX in the Treatment for Locally Advanced Rectal Cancer | completed | Phase 2 | 118 | Hebei Medical University Fourth HospitalOTHER | 1 | Aug 22, 2024 | clinicaltrials |
| NCT00297791 | COLOR II: Laparoscopic Versus Open Rectal Cancer Removal(COLORII) | completed | Phase 3 | 1,044 | Nova Scotia Health AuthorityOTHER | 9 | Aug 21, 2024 | clinicaltrials |
| NCT06022887 | Time-Restricted Eating and Mindfulness-Based Stress Reduction to Reduce the Risk of Early-Onset Colorectal Cancer(MBSR&TRE) | completed | N/A | 43 | Lisa Tussing-HumphreysOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT02743221 | A Study Evaluating S 95005 Plus Bevacizumab and Capecitabine Plus Bevacizumab in Patients With Previously Untreated Colorectal Cancer Who Are Non-eligible for Intensive Therapy(TASCO1) | completed | Phase 2 | 154 | Institut de Recherches Internationales ServierOTHER | 12 | Aug 20, 2024 | clinicaltrials |
Data updated 24 days agoSource updated Oct 21, 2024source: clinicaltrials